Tina Marriott Larson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Tina Marriott Larson is President and COO of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 506,852 shares of RXRX, which is worth approximately $2.99 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 14,286 shares (Class A Common Stock) at a price of $6.17 per share, resulting in proceeds of $88,144. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 507K

2.74% 3M change

22.6% 12M change

Total Value Held $2.99 Million

Tina Marriott Larson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	SELL Payment of exercise price or tax liability	$88,144 $6.17 p/Share	14,286 Reduced 2.74%	506,852 Class A Common Stock
Oct 24 2024	SELL Open market or private sale	$37,860 $6.31 p/Share	6,000 Reduced 1.14%	521,138 Class A Common Stock
Oct 24 2024	BUY Exercise of conversion of derivative security	$6,360 $1.06 p/Share	6,000 Added 1.13%	527,138 Class A Common Stock
Sep 26 2024	SELL Open market or private sale	$42,000 $7.0 p/Share	6,000 Reduced 1.14%	521,138 Class A Common Stock
Sep 26 2024	BUY Exercise of conversion of derivative security	$6,360 $1.06 p/Share	6,000 Added 1.13%	527,138 Class A Common Stock
Aug 29 2024	SELL Open market or private sale	$45,360 $7.56 p/Share	6,000 Reduced 1.14%	521,138 Class A Common Stock
Aug 29 2024	BUY Exercise of conversion of derivative security	$6,360 $1.06 p/Share	6,000 Added 1.13%	527,138 Class A Common Stock
Aug 15 2024	SELL Payment of exercise price or tax liability	$95,794 $6.69 p/Share	14,319 Reduced 2.67%	521,138 Class A Common Stock
Jul 25 2024	SELL Open market or private sale	$48,780 $8.13 p/Share	6,000 Reduced 1.11%	535,457 Class A Common Stock
Jul 25 2024	BUY Exercise of conversion of derivative security	$6,360 $1.06 p/Share	6,000 Added 1.1%	541,457 Class A Common Stock
Jun 27 2024	SELL Open market or private sale	$43,260 $7.21 p/Share	6,000 Reduced 1.11%	535,457 Class A Common Stock
Jun 27 2024	BUY Exercise of conversion of derivative security	$6,360 $1.06 p/Share	6,000 Added 1.1%	541,457 Class A Common Stock
May 30 2024	SELL Open market or private sale	$26,339 $8.78 p/Share	3,000 Reduced 0.56%	535,457 Class A Common Stock
May 30 2024	BUY Exercise of conversion of derivative security	$3,180 $1.06 p/Share	3,000 Added 0.55%	538,457 Class A Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$100,079 $10.01 p/Share	9,998 Reduced 1.84%	533,233 Class A Common Stock
Apr 25 2024	SELL Open market or private sale	$23,010 $7.67 p/Share	3,000 Reduced 0.55%	543,231 Class A Common Stock
Apr 25 2024	BUY Exercise of conversion of derivative security	$3,180 $1.06 p/Share	3,000 Added 0.55%	546,231 Class A Common Stock
Mar 21 2024	SELL Open market or private sale	$88,160 $11.02 p/Share	8,000 Reduced 1.23%	639,982 Class A Common Stock
Mar 21 2024	BUY Exercise of conversion of derivative security	$8,480 $1.06 p/Share	8,000 Added 1.22%	647,982 Class A Common Stock
Feb 22 2024	SELL Open market or private sale	$119,120 $14.89 p/Share	8,000 Reduced 1.23%	639,982 Class A Common Stock
Feb 22 2024	BUY Exercise of conversion of derivative security	$8,480 $1.06 p/Share	8,000 Added 1.22%	647,982 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$66,860 $12.43 p/Share	5,379 Reduced 0.83%	639,982 Class A Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$28,252 $10.09 p/Share	2,800 Reduced 0.43%	645,361 Class A Common Stock
Feb 09 2024	BUY Grant, award, or other acquisition	-	233,613 Added 26.49%	648,161 Class A Common Stock
Jan 25 2024	SELL Open market or private sale	$82,800 $10.35 p/Share	8,000 Reduced 1.89%	414,548 Class A Common Stock

TML

Tina Marriott Larson

President and COO

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account